Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Lymphocyte Receptor”

1,059 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,059 results

Testing effectiveness (Phase 2)WithdrawnNCT02390739
What this trial is testing

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer

Who this might be right for
Metastatic Thyroid Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT04762485
What this trial is testing

Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia

Who this might be right for
T Lymphoblastic Leukemia/LymphomaMixed Phenotype Acute LeukemiaAcute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 20
Early research (Phase 1)Active Not RecruitingNCT04511871
What this trial is testing

A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors

Who this might be right for
Solid TumorGastric CancerBreast Cancer+2 more
Shanghai PerHum Therapeutics Co., Ltd. 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06777264
What this trial is testing

Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1

Who this might be right for
Acute Lymphoblastic LeukemiaB Cell ALL
First Affiliated Hospital of Zhejiang University 20
Not applicableUnknownNCT03423706
What this trial is testing

Clinical Studies of New Model Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
CD19-chimeric Antigen Receptor T CellsRelapsed and/or Refractory Acute Lymphoblastic Leukemiathe Haploidentical Hematopoietic Stem Cell Transplantation
First Affiliated Hospital of Harbin Medical University 50
Early research (Phase 1)Not Yet RecruitingNCT07335328
What this trial is testing

Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies

Who this might be right for
B-cell Non Hodgkin Lymphoma
Medical College of Wisconsin 24
Early research (Phase 1)UnknownNCT04712864
What this trial is testing

Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma

Who this might be right for
T-Cell LymphomaPeripheral T-Cell Lymphoma RefractoryCutaneous T-Cell Lymphoma Refractory+2 more
Legend Biotech USA Inc 50
Early research (Phase 1)Looking for participantsNCT06875063
What this trial is testing

GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL

Who this might be right for
Non-hodgkin LymphomaRefractory LymphomaChimeric Antigen Receptor T-cell
The First Affiliated Hospital of Xiamen University 45
Early research (Phase 1)Looking for participantsNCT05388695
What this trial is testing

To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors

Who this might be right for
19 and 22+ B Cell Hematologic Tumors19 and 20+ B Cell Hematologic Tumors
Hebei Senlang Biotechnology Inc., Ltd. 100
Early research (Phase 1)Looking for participantsNCT04020575
What this trial is testing

Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

Who this might be right for
Metastatic Breast Cancer
Minerva Biotechnologies Corporation 69
Not applicableLooking for participantsNCT06866873
What this trial is testing

CD-19 CAR-T Cell for Pediatric ALL or Lymphoma

Who this might be right for
Lymphoma, B-CellAcute Lymphoblastic Leukemia, Pediatric
Hong Kong Children's Hospital 18
Not applicableUnknownNCT06142175
What this trial is testing

Relmacabtagene Autoleucel in Patients With LBCL

Who this might be right for
Large B-cell Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd. 200
Very early researchUnknownNCT04923919
What this trial is testing

Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 100
Early research (Phase 1)Study completedNCT00019136
What this trial is testing

Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT04083495
What this trial is testing

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
UNC Lineberger Comprehensive Cancer Center 20
Early research (Phase 1)UnknownNCT03706547
What this trial is testing

Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R MM

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma Progression
Peng Liu 20
Early research (Phase 1)Study completedNCT05022849
What this trial is testing

JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 15
Early research (Phase 1)Ended earlyNCT04633148
What this trial is testing

Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Marker

Who this might be right for
Prostate Cancer
AvenCell Europe GmbH 16
Testing effectiveness (Phase 2)UnknownNCT01864902
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33

Who this might be right for
Relapsed Adult Myeloid LeukemiaChemotherapy Refractory Adult Myeloid Leukemia
Chinese PLA General Hospital 10
Testing effectiveness (Phase 2)UnknownNCT05651100
What this trial is testing

Safety and Efficacy of Sequential CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Kecellitics Biotech Company Ltd 50
Load More Results